Patents Assigned to VISION PHARMA PTY LTD
  • Retinitis pigmentosa treatment
    Patent number: 12649922
    Abstract: An isolated or purified antisense oligomer for modifying pre-mRNA splicing in the CNOT3 gene transcript or part thereof.
    Type: Grant
    Filed: July 31, 2024
    Date of Patent: June 9, 2026
    Assignee: Vision Pharma PTY LTD
    Inventors: Sue Fletcher, Ianthe Pitout, Janya Grainok, Steve D. Wilton, Fred K. Chen
  • Retinitis pigmentosa treatment
    Patent number: 12559747
    Abstract: An isolated or purified antisense oligomer for modifying pre-mRNA splicing in the CNOT3 gene transcript or part thereof.
    Type: Grant
    Filed: May 25, 2020
    Date of Patent: February 24, 2026
    Assignee: VISION PHARMA PTY LTD
    Inventors: Sue Fletcher, Ianthe Pitout, Jayna Grainok, Steve D. Wilton, Fred K. Chen